Literature DB >> 29926204

Molecular Therapies for Muscular Dystrophies.

Ava Y Lin1, Leo H Wang2.   

Abstract

PURPOSE OF REVIEW: To construct a framework to understand the different molecular interventions for muscular dystrophy. RECENT
FINDINGS: The recent approval of antisense oligonucleotides treatment for Duchenne muscular dystrophy and spinal muscular atrophy and current clinical trials using recombinant adeno-associated virus for the treatment of those diseases suggests that we are at a tipping point where we are able to treat and potentially cure muscular dystrophies. Understanding the basic molecular pathogenesis of muscular dystrophies and the molecular biology of the treatment allows for critical evaluation of the proposed therapies.

Entities:  

Keywords:  Gene therapy; Limb-girdle muscular dystrophy; Molecular therapies; Muscular dystrophy; Therapies

Year:  2018        PMID: 29926204     DOI: 10.1007/s11940-018-0509-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  226 in total

Review 1.  Stem cell therapies to treat muscular dystrophy: progress to date.

Authors:  Mirella Meregalli; Andrea Farini; Daniele Parolini; Simona Maciotta; Yvan Torrente
Journal:  BioDrugs       Date:  2010-08-01       Impact factor: 5.807

2.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

3.  Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.

Authors:  Matthew Elverman; Melissa A Goddard; David Mack; Jessica M Snyder; Michael W Lawlor; Hui Meng; Alan H Beggs; Ana Buj-Bello; Karine Poulard; Anthony P Marsh; Robert W Grange; Valerie E Kelly; Martin K Childers
Journal:  Muscle Nerve       Date:  2017-05-22       Impact factor: 3.217

4.  Precise small-molecule recognition of a toxic CUG RNA repeat expansion.

Authors:  Suzanne G Rzuczek; Lesley A Colgan; Yoshio Nakai; Michael D Cameron; Denis Furling; Ryohei Yasuda; Matthew D Disney
Journal:  Nat Chem Biol       Date:  2016-12-12       Impact factor: 15.040

Review 5.  Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.

Authors:  Annemieke Aartsma-Rus; Ivo Fokkema; Jan Verschuuren; Ieke Ginjaar; Judith van Deutekom; Gert-Jan van Ommen; Johan T den Dunnen
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

6.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

7.  Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo.

Authors:  Evelyne M Houang; Karen J Haman; Antonio Filareto; Rita C Perlingeiro; Frank S Bates; Dawn A Lowe; Joseph M Metzger
Journal:  Mol Ther Methods Clin Dev       Date:  2015-11-11       Impact factor: 6.698

8.  Delivery of large transgene cassettes by foamy virus vector.

Authors:  Nathan Paul Sweeney; Jinhong Meng; Hayley Patterson; Jennifer E Morgan; Myra McClure
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

9.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

Review 10.  The role of corticosteroids in muscular dystrophy: a critical appraisal.

Authors:  Corrado Angelini
Journal:  Muscle Nerve       Date:  2007-10       Impact factor: 3.217

View more
  2 in total

1.  Pericytes in Muscular Dystrophies.

Authors:  Louise Anne Moyle; Francesco Saverio Tedesco; Sara Benedetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 2.  New Directions for SMA Therapy.

Authors:  Sonia Messina
Journal:  J Clin Med       Date:  2018-08-31       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.